Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Heuman

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
The Journal of Steroid Biochemistry and Molecular Biology|May 6, 1998
Metabolic fate and hepatocyte toxicity of reverse amide analogs of conjugated ursodeoxycholate in the ratJ P Coleman, L C Kirby, K D Setchell, et al.
The American Journal of Physiology|April 1, 1996
Transcriptional regulation of hepatic sterol 27-hydroxylase by bile acidsZ R Vlahcevic, S K Jairath, D M Heuman, et al.
The Journal of Biological Chemistry|May 25, 1991
Effect of hydrophobic bile acids on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and mRNA levels in the ratP F Duckworth, Z R Vlahcevic, E J Studer, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 15, 2001
Effects of CYP7A1 overexpression on cholesterol and bile acid homeostasisW M Pandak, C Schwarz, P B Hylemon, et al.
The Journal of Biological Chemistry|July 5, 1993
Transcriptional regulation of cholesterol 7 alpha-hydroxylase mRNA by conjugated bile acids in primary cultures of rat hepatocytesR T Stravitz, P B Hylemon, D M Heuman, et al.
The Journal of Biological Chemistry|February 25, 1991
Regulation of cholesterol 7 alpha-hydroxylase mRNA and transcriptional activity by taurocholate and cholesterol in the chronic biliary diverted ratW M Pandak, Y C Li, J Y Chiang, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2016
HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patientsJ S Bajaj, R K Sterling, N S Betrapally, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2011
PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosisJ S Bajaj, L R Thacker, J B Wade, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2012
Modified-orientation log to assess hepatic encephalopathyM Salam, S Matherly, I S Farooq, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2014
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosisJ S Bajaj, D M Heuman, P B Hylemon, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Journal of Steroid Biochemistry and Molecular Biology|May 6, 1998
Metabolic fate and hepatocyte toxicity of reverse amide analogs of conjugated ursodeoxycholate in the ratJ P Coleman, L C Kirby, K D Setchell, et al.
The American Journal of Physiology|April 1, 1996
Transcriptional regulation of hepatic sterol 27-hydroxylase by bile acidsZ R Vlahcevic, S K Jairath, D M Heuman, et al.
The Journal of Biological Chemistry|May 25, 1991
Effect of hydrophobic bile acids on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and mRNA levels in the ratP F Duckworth, Z R Vlahcevic, E J Studer, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 15, 2001
Effects of CYP7A1 overexpression on cholesterol and bile acid homeostasisW M Pandak, C Schwarz, P B Hylemon, et al.
The Journal of Biological Chemistry|July 5, 1993
Transcriptional regulation of cholesterol 7 alpha-hydroxylase mRNA by conjugated bile acids in primary cultures of rat hepatocytesR T Stravitz, P B Hylemon, D M Heuman, et al.
The Journal of Biological Chemistry|February 25, 1991
Regulation of cholesterol 7 alpha-hydroxylase mRNA and transcriptional activity by taurocholate and cholesterol in the chronic biliary diverted ratW M Pandak, Y C Li, J Y Chiang, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2016
HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patientsJ S Bajaj, R K Sterling, N S Betrapally, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2011
PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosisJ S Bajaj, L R Thacker, J B Wade, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2012
Modified-orientation log to assess hepatic encephalopathyM Salam, S Matherly, I S Farooq, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2014
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosisJ S Bajaj, D M Heuman, P B Hylemon, et al.
Pageof 6